Solventum (NYSE:SOLV – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Thursday, May 9th. Analysts expect Solventum to post earnings of $1.67 per share for the quarter.
Solventum Stock Performance
NYSE:SOLV opened at $65.56 on Wednesday. Solventum has a one year low of $60.72 and a one year high of $96.05.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on SOLV shares. Wells Fargo & Company began coverage on Solventum in a research note on Monday, April 8th. They set an “equal weight” rating and a $69.00 price objective for the company. Edward Jones initiated coverage on shares of Solventum in a research report on Tuesday, April 2nd. They set a “hold” rating for the company. Finally, Morgan Stanley assumed coverage on Solventum in a research report on Wednesday, April 10th. They issued an “equal weight” rating and a $70.00 price objective on the stock.
Solventum Company Profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
See Also
- Five stocks we like better than Solventum
- What Are Trending Stocks? Trending Stocks Explained
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is the Hang Seng index?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Most Volatile Stocks, What Investors Need to Know
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.